-+ 0.00%
-+ 0.00%
-+ 0.00%

*Royalty Pharma: Rusfertide (PTG-300) Is a Potential First-In-Class Therapy for Polycythemia Vera, a Rare and Chronic Blood Disorder >RPRX

Dow Jones·08/12/2026 20:26:00

Please log in to view news